Dr Katherine Neville

  • BMed, FRANZCR, MClinEpid
  • Radiation Oncologist
  • Spoken languages English


Special clinical interest in breast, skin, lung cancer, palliative radiotherapy and haematology

Dr Katherine Neville is an Australian trained Radiation Oncologist. She completed her undergraduate degree at the University of Newcastle in 2005 and worked throughout Hunter New England Area Health Service as a junior doctor before commencing specialty training in Radiation Oncology in 2009. Dr Neville completed her specialist training at the Calvary Mater Hospital, Royal North Shore Hospital, and Liverpool Hospital before being becoming a Fellow of the Royal Australian and New Zealand College of Radiologists (Faculty of Radiation Oncology) in 2016. She has received training in the management of all tumour types, however, has a special interest in the treatment of breast cancer, lung cancer, benign diseases, haematology and the use of radiation for symptom control in advanced cancer.

As well as her clinical interests, Dr Neville has completed research projects in the use of radiotherapy for Mantle Cell Lymphoma, Non-Small Cell Lung Cancer, and Breast Cancer. She has completed her Masters of Clinical Epidemiology through the University of Newcastle.

Dr Neville consults at the Multi-disciplinary Dupuytren’s clinic in Newcastle and is co-investigator on the DEPART clinical trial.

Research interests

  • Dupuytrens disease

Publications and affiliations

  • Adoption of hypofractionated radiation therapy for early breast cancer in private practice: the GenesisCare experience 2014–2106. Journal of Medical Imaging and Radiation Oncology (JMIRO). 2020
  • Involved-field radiotherapy for patients with mantle cell lymphoma. Journal of Medical Imaging and Radiation Oncology (JMIRO) 2015

Professional memberships

  • Australian & New Zealand College of Radiologists
  • TROG (Trans Tasman Radiation Oncology Group)
  • ESTRO (European Society for Radiotherapy & Oncology)
  • ANZPROG (RANZCR Australian and New Zealand Palliative Radiation Oncology Group)